Sign in
NMTR Stock Price, Chart, Stats & News
9 Meters Biopharma, Inc.
Save
9 Meters Biopharma, Inc. (NMTR) does not currently pay a dividend.
1.04M
Market cap
–
Current P/E
–
Forward P/E
NMTR chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -4.00% |
ROA | -137.31% |
ROE | -206.87% |
D/E | 8.22x |
Interest coverage ratio | -15.75x |
NMTR valuation
P/E | – |
P/S | – |
P/B | 0.39x |
P/CF | -0.03x |
P/FCF | -0.03x |
P/OCF | -0.03x |
PEG | -0.00x |
EV multiple | 0.15x |
About
Based in Raleigh, North Carolina, 9 Meters Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. Its core mission is to innovate treatments for individuals suffering from rare digestive conditions, gastrointestinal disorders with inadequate therapeutic options, and other severe debilitating ailments. The company's pipeline features several promising drug candidates.
Similar securities
Based on sector and market capitalization
Report issue